How Much Does a GLP-1 Cost in 2026? Full Price Breakdown

GLP-1 prices in 2026: list prices, insurance copays, manufacturer savings, LillyDirect cash pay, and the compounded market — by brand.

PeptideStat Editorial Team6 min read
How Much Does a GLP-1 Cost in 2026? Full Price Breakdown

There's no single "GLP-1 price." There are at least six prices for the same molecule, depending on the brand, your insurance, your prescriber's relationships with manufacturers, and whether you're open to compounded versions. This guide walks each path with the dollar amounts that are actually quoted in early 2026.

List prices for the major GLP-1s

These are the sticker (cash, no-discount) prices in the US for a 28-day supply in early 2026:

| Brand | Active ingredient | Approved use | Monthly list | | --- | --- | --- | --- | | Ozempic | Semaglutide | Type 2 diabetes | $968 – $1,028 | | Wegovy | Semaglutide | Weight management; CV risk; MASH | $1,349 | | Mounjaro | Tirzepatide | Type 2 diabetes | $1,069 | | Zepbound (pens) | Tirzepatide | Weight management; OSA | $1,299 | | Zepbound (LillyDirect vials) | Tirzepatide | Weight management | $349 (2.5 mg) – $499 (5 mg) | | Saxenda | Liraglutide | Weight management | $1,349 | | Rybelsus (oral) | Semaglutide | Type 2 diabetes | $999 |

These figures move as manufacturers adjust pricing. Lilly publicly indicated reductions in Wegovy and Ozempic list pricing of up to 50% in coverage tiers during 2026.

The real out-of-pocket equation

What you actually pay depends on four variables, in order of impact:

  1. Does your insurance cover GLP-1s for your indication? Diabetes coverage is broad. Weight-loss coverage is improving but still patchy.
  2. Does the manufacturer copay card apply to you? Commercial insurance: usually yes. Medicare / Medicaid / TRICARE: usually no.
  3. Is the price you're being quoted brand or compounded? Compounded is roughly 60–75% cheaper.
  4. Are you buying through a telehealth program? Programs add a monthly fee (typically $99–$299) on top of the medication.

A worked example:

  • Wegovy list price: $1,349/month
  • With Novo's savings card on commercial insurance: $25/month
  • Without insurance, with the savings card: ~$650/month
  • Compounded semaglutide via 503A pharmacy: $199–$299/month

That's the same active ingredient at a 50× cost ratio.

Insurance coverage in 2026

Three changes have been moving the coverage market:

  • Wegovy and Zepbound now have FDA approvals beyond weight loss (cardiovascular risk reduction for Wegovy, OSA for Zepbound). Both expansions widen the cases where insurance covers them.
  • Medicaid broader coverage for weight-loss GLP-1s started rolling out through the CMS BALANCE model in 2025-2026.
  • Medicare Part D coverage for weight-loss GLP-1s is currently signaled to begin January 2027 under the same BALANCE pathway.

For employer plans, ask your pharmacy benefits manager (number is on your insurance card) two questions:

  1. Is [drug] on the formulary, and at what tier?
  2. Is prior authorization required, and what does the criteria say?

Most plans use BMI thresholds (≥ 30, or ≥ 27 with a comorbidity) for the weight-loss indications.

Manufacturer savings cards

The single biggest lever for commercially insured patients.

Novo Nordisk savings programs

  • Wegovy Savings Offer: $0 copay for eligible insured patients up to $225/month; cash-pay reduced to roughly $650/month
  • Ozempic Savings Card: $25/copay for eligible insured patients

Eli Lilly savings programs

  • Zepbound Savings Card: $25 copay for commercially insured patients whose plans cover it; for those whose plans don't cover Zepbound, reduced cash-pay rates apply
  • LillyDirect Zepbound vials: $349–$499/month direct cash pay, without a copay card

Each program has eligibility fine print. None apply to Medicare, Medicaid, or federal benefit programs.

Compounded GLP-1 pricing

When a US-licensed compounding pharmacy (503A or 503B) mixes the active ingredient, prices drop sharply:

| Drug | Compounded price range | | --- | --- | | Semaglutide | $199–$299/month | | Tirzepatide | $249–$349/month |

Caveats:

  • The FDA declared the official shortage over for both molecules in 2024-2025, narrowing what 503B outsourcing facilities can compound at scale. Compounded GLP-1 remains legal under patient-specific 503A pathways but supply has tightened.
  • Compounded preparations vary by pharmacy. Reputable pharmacies follow USP standards.
  • Most insurance plans don't cover compounded drugs.

See compounded GLP-1 for the legality.

Telehealth program fees

If you're not seeing a primary care provider in person, telehealth platforms typically charge a program fee on top of the medication:

| Provider | Monthly fee (excl. drug) | Drug cost separate | | --- | --- | --- | | Eden | $129 first, then $209 | Bundled | | Medvi | $179 first, $299 after | Bundled | | Ro Body Program | $145 | Drug separate, often via insurance | | Hims/Hers | $199 (compounded GLP-1 included) | Bundled | | Weight Watchers Clinic | $839/year | Drug separate |

The bundle-vs-separate distinction matters: when the drug cost is "separate", you may still pay $1,000+ on top of the fee. When it's "bundled", the headline number is roughly the total.

How to actually save money

Ordered by likely impact:

  1. Find out what your insurance covers before you pick a brand. A covered Wegovy at $25 copay beats every other option.
  2. Apply the manufacturer copay card if you're commercially insured.
  3. Compare LillyDirect vials vs your telehealth Zepbound quote. The vials are often dramatically cheaper.
  4. Compare compounded prices across at least two reputable 503A pharmacies if you go that route.
  5. Use HSA / FSA dollars for the prescription portion — effectively a 22–37% discount via pre-tax dollars.
  6. Ask about dose-pause programs — some plans cover the drug at the minimum effective dose, not always the highest.

What doesn't really save money

  • GoodRx coupons rarely beat manufacturer pricing on the headline GLP-1s.
  • Ordering Ozempic for weight loss when Wegovy is on your formulary — the off-label price is almost always higher.
  • Switching pharmacies repeatedly — markups don't vary much among legitimate retail pharmacies.

FAQ

What is the average cost of a GLP-1 per month? With commercial insurance and a savings card: $25–$100. Without insurance but with the manufacturer cash-pay program: $349–$700. Compounded: $199–$349. Brand-name without any discount: $968–$1,400.

Why is Ozempic so expensive in the US? US pricing for branded prescription drugs reflects the manufacturer's list price plus pharmacy markup plus PBM rebates. The same drugs sell for much less in other countries with reference pricing.

Will GLP-1 prices come down soon? Some — Lilly indicated up to 50% list price reductions for certain coverage tiers. But generic semaglutide isn't expected before the early 2030s; meaningful sustained price reductions are tied to coverage and manufacturer programs in the near term.

Is there a cheap GLP-1 alternative without a prescription? No legal one. Sites selling "research peptide" semaglutide vials for $30 are outside the prescription system and unsafe.

For the head-to-head ranking of the most affordable paths, see cheapest GLP-1 for weight loss.


This article is for educational purposes only and is not medical advice. Prices change frequently and vary by state, plan and pharmacy. Verify current quotes with the provider and your insurer.

glp-1pricingcostbuying guide

Related database entries

Jump from this guide into structured peptide database pages with evidence scores, status and mechanism notes.

Liraglutide

Victoza, Saxenda

5/5
Weight lossApproved

Daily GLP-1 analog. Reduces appetite and improves glycemic control via the same incretin pathway as semaglutide.

Semaglutide

Ozempic, Wegovy, Rybelsus

5/5
Weight lossApproved

Mimics the incretin GLP-1, slowing gastric emptying and reducing appetite while improving insulin secretion.

Tirzepatide

LY3298176, Mounjaro, Zepbound

5/5
Weight lossApproved

Activates GLP-1 and GIP receptors to improve glycemic control and reduce appetite + body weight.

4/5
Weight lossInvestigational

Long-acting amylin analog that slows gastric emptying and reinforces satiety; studied in combination with semaglutide (CagriSema).

Retatrutide

LY3437943

4/5
Weight lossInvestigational

Activates GLP-1, GIP and glucagon receptors simultaneously to suppress appetite and raise energy expenditure.

Related peptide categories

Compare the wider category before going deeper on a single compound.

Related guides